Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Breen

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Brain : a Journal of Neurology|August 1, 2014
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD studyCristina Nombela, James B Rowe, Sophie E Winder-Rhodes, et al.
Neurology|December 24, 2013
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD studyAlison J Yarnall, David P Breen, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 24, 2020
Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter HyperintensitiesJoel Ramirez, Allison A Dilliott, Malcolm A Binns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2022
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease PatientsJoel Ramirez, Stephanie A Berberian, David P Breen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
American Journal of Human Genetics|June 25, 2019
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVASHaloom Rafehi, David J Szmulewicz, Mark F Bennett, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Brain : a Journal of Neurology|August 1, 2014
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD studyCristina Nombela, James B Rowe, Sophie E Winder-Rhodes, et al.
Neurology|December 24, 2013
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD studyAlison J Yarnall, David P Breen, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 24, 2020
Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter HyperintensitiesJoel Ramirez, Allison A Dilliott, Malcolm A Binns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2022
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease PatientsJoel Ramirez, Stephanie A Berberian, David P Breen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
American Journal of Human Genetics|June 25, 2019
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVASHaloom Rafehi, David J Szmulewicz, Mark F Bennett, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Pageof 10